AWARDBPA CALLOther than small business
BPA call 75F40121F19005DELOITTE & TOUCHE LLP
Overview
Award facts
- Net obligations
- $6.49M
- $6,494,716of $10.72M potential value
- Outlays (paid to date)
- $6.49M
- $6.49M paid of $6.49M obligated$6,494,716
- Period of performance
- Sep 17, 2021 to Jul 7, 2026
- Ended
- Modifications
- 18
- Latest action Jan 6, 2026
- Contract type
- BPA call
- PIID 75F40121F19005
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
MATURING THE INTERNAL CONTROLS SYSTEM AT FDA BLANKET PURCHASE AGREEMENT (BPA) TASK SUPPORT FOR FY 2021 A-123 INTERNAL CONTROLS ASSESSMENTS
Dates and value
- Award date
- Signed on Sep 17, 2021
- Potential end of performance
- Jul 6, 2026
- Current value
- $7,051,014Base and exercised options
- Potential value (if all options are exercised)
- $10,721,691
- Parent contract vehicle
- 75F40120A00023 (BPA, single award) — 10 orders recorded under it
Obligations by fiscal year of action
- FY2025: $272,958
- FY2024: $1,787,474
- FY2023: $1,998,924
- FY2022: $1,786,729
- FY2021: $648,630
Total across 5 fiscal years: $6,494,716
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 6, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationARLINGTON, VA
UEIF9KSDU7L9VP6
CAGE code3CCJ5
Business sizeOther than small businessSize at award, per the contracting officer
Organization typePartnership
Parent companyDELOITTE CONSULTING LLP
Business types and certifications
For-profit organizationPartnership or LLP
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Fda working capital fundProgram activities075-4613Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Arlington, Virginia 22209-1742
- Congressional district (place of performance)
- VA-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- R703SUPPORT- MANAGEMENT: ACCOUNTING (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- Not reported
- Contract pricing
- Firm fixed priceJ
Solicitation and notices
- Solicitation ID
- 1238945(as reported)
- Solicitation date
- Feb 26, 2021
Contract details
- Certified cost or pricing data
- Yes
- Service Contract Act labor standards
- Yes
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- Other undefinitized actionB
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 17, 2021Base obligation at award: $648,630
- Latest action
- Jan 6, 2026 — Other administrative actionModification P00018; administrative: no change in scope or value
- Latest substantive action
- Dec 21, 2021 — Option exercisedModification P00003; obligation change +$1,597,287
- Actions by type
- Base award1
- Other administrative action15
- Supplemental agreement (within scope)1
- Change order1
- Option exercised1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Closely associatedCL
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- BPA callA
- Parent vehicle type
- BPAE
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 19
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-X-4613-000
- Object classes
- 25.1: Advisory and assistance services
- 25.2: Other services from non-Federal sources
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression